Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.
Identifieur interne : 000575 ( Main/Exploration ); précédent : 000574; suivant : 000576Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.
Auteurs : Salman Ali Khan [Pakistan] ; Komal Zia [Pakistan] ; Sajda Ashraf [Pakistan] ; Reaz Uddin [Pakistan] ; Zaheer Ul-Haq [Pakistan]Source :
- Journal of biomolecular structure & dynamics [ 1538-0254 ] ; 2020.
Abstract
Recently, the world has witnessed outbreak of a novel Coronavirus (SARS-CoV-2), the virus which initially emerged in Wuhan, China has now made its way to a large part of the world, resulting in a public emergency of international concern. The functional importance of Chymotrypsin-like protease (3CLpro) in viral replication and maturation turns it into an attractive target for the development of effective antiviral drugs against SARS and other coronaviruses. At present, there is no standard drug regime nor any vaccine available against the infection. The rapid development and identification of efficient interventions against SARS-CoV-2 remains a major challenge. Based on the available knowledge of closely related coronavirus and their safety profiles, repurposing of existing antiviral drugs and screening of available databases is considered a near term strategic and economic way to contain the SARS-CoV-2 pandemic. Herein, we applied computational drug design methods to identify Chymotrypsin-like protease inhibitors from FDA approved antiviral drugs and our in-house database of natural and drug-like compounds of synthetic origin. As a result three FDA approved drugs (Remdesivir, Saquinavir and Darunavir) and two natural compounds (. flavone and coumarine derivatives) were identified as promising hits. Further, MD simulation and binding free energy calculations were performed to evaluate the dynamic behavior, stability of protein-ligand contact, and binding affinity of the hit compounds. Our results indicate that the identified compounds can inhibit the function of Chymotrypsin-like protease (3CLpro) of Coronavirus. Considering the severity of the spread of coronavirus, the current study is in-line with the concept of finding the new inhibitors against the vital pathway of the corona virus to expedite the process of drug discovery.Communicated by Ramaswamy H. Sarma.
DOI: 10.1080/07391102.2020.1751298
PubMed: 32238094
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000406
- to stream PubMed, to step Curation: 000406
- to stream PubMed, to step Checkpoint: 000458
- to stream Ncbi, to step Merge: 003688
- to stream Ncbi, to step Curation: 003688
- to stream Ncbi, to step Checkpoint: 003688
- to stream Main, to step Merge: 000575
- to stream Main, to step Curation: 000575
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 <i>via</i>
integrated computational approach.</title>
<author><name sortKey="Khan, Salman Ali" sort="Khan, Salman Ali" uniqKey="Khan S" first="Salman Ali" last="Khan">Salman Ali Khan</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zia, Komal" sort="Zia, Komal" uniqKey="Zia K" first="Komal" last="Zia">Komal Zia</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ashraf, Sajda" sort="Ashraf, Sajda" uniqKey="Ashraf S" first="Sajda" last="Ashraf">Sajda Ashraf</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Uddin, Reaz" sort="Uddin, Reaz" uniqKey="Uddin R" first="Reaz" last="Uddin">Reaz Uddin</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ul Haq, Zaheer" sort="Ul Haq, Zaheer" uniqKey="Ul Haq Z" first="Zaheer" last="Ul-Haq">Zaheer Ul-Haq</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32238094</idno>
<idno type="pmid">32238094</idno>
<idno type="doi">10.1080/07391102.2020.1751298</idno>
<idno type="wicri:Area/PubMed/Corpus">000406</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000406</idno>
<idno type="wicri:Area/PubMed/Curation">000406</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000406</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000458</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000458</idno>
<idno type="wicri:Area/Ncbi/Merge">003688</idno>
<idno type="wicri:Area/Ncbi/Curation">003688</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003688</idno>
<idno type="wicri:Area/Main/Merge">000575</idno>
<idno type="wicri:Area/Main/Curation">000575</idno>
<idno type="wicri:Area/Main/Exploration">000575</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 <i>via</i>
integrated computational approach.</title>
<author><name sortKey="Khan, Salman Ali" sort="Khan, Salman Ali" uniqKey="Khan S" first="Salman Ali" last="Khan">Salman Ali Khan</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zia, Komal" sort="Zia, Komal" uniqKey="Zia K" first="Komal" last="Zia">Komal Zia</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ashraf, Sajda" sort="Ashraf, Sajda" uniqKey="Ashraf S" first="Sajda" last="Ashraf">Sajda Ashraf</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Uddin, Reaz" sort="Uddin, Reaz" uniqKey="Uddin R" first="Reaz" last="Uddin">Reaz Uddin</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ul Haq, Zaheer" sort="Ul Haq, Zaheer" uniqKey="Ul Haq Z" first="Zaheer" last="Ul-Haq">Zaheer Ul-Haq</name>
<affiliation wicri:level="1"><nlm:affiliation>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.</nlm:affiliation>
<country xml:lang="fr">Pakistan</country>
<wicri:regionArea>Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi</wicri:regionArea>
<wicri:noRegion>Karachi</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of biomolecular structure & dynamics</title>
<idno type="eISSN">1538-0254</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Recently, the world has witnessed outbreak of a novel Coronavirus (SARS-CoV-2), the virus which initially emerged in Wuhan, China has now made its way to a large part of the world, resulting in a public emergency of international concern. The functional importance of Chymotrypsin-like protease (3CL<sup>pro</sup>
) in viral replication and maturation turns it into an attractive target for the development of effective antiviral drugs against SARS and other coronaviruses. At present, there is no standard drug regime nor any vaccine available against the infection. The rapid development and identification of efficient interventions against SARS-CoV-2 remains a major challenge. Based on the available knowledge of closely related coronavirus and their safety profiles, repurposing of existing antiviral drugs and screening of available databases is considered a near term strategic and economic way to contain the SARS-CoV-2 pandemic. Herein, we applied computational drug design methods to identify Chymotrypsin-like protease inhibitors from FDA approved antiviral drugs and our in-house database of natural and drug-like compounds of synthetic origin. As a result three FDA approved drugs (Remdesivir, Saquinavir and Darunavir) and two natural compounds (. flavone and coumarine derivatives) were identified as promising hits. Further, MD simulation and binding free energy calculations were performed to evaluate the dynamic behavior, stability of protein-ligand contact, and binding affinity of the hit compounds. Our results indicate that the identified compounds can inhibit the function of Chymotrypsin-like protease (3CL<sup>pro</sup>
) of Coronavirus. Considering the severity of the spread of coronavirus, the current study is in-line with the concept of finding the new inhibitors against the vital pathway of the corona virus to expedite the process of drug discovery.Communicated by Ramaswamy H. Sarma.</div>
</front>
</TEI>
<affiliations><list><country><li>Pakistan</li>
</country>
</list>
<tree><country name="Pakistan"><noRegion><name sortKey="Khan, Salman Ali" sort="Khan, Salman Ali" uniqKey="Khan S" first="Salman Ali" last="Khan">Salman Ali Khan</name>
</noRegion>
<name sortKey="Ashraf, Sajda" sort="Ashraf, Sajda" uniqKey="Ashraf S" first="Sajda" last="Ashraf">Sajda Ashraf</name>
<name sortKey="Uddin, Reaz" sort="Uddin, Reaz" uniqKey="Uddin R" first="Reaz" last="Uddin">Reaz Uddin</name>
<name sortKey="Ul Haq, Zaheer" sort="Ul Haq, Zaheer" uniqKey="Ul Haq Z" first="Zaheer" last="Ul-Haq">Zaheer Ul-Haq</name>
<name sortKey="Zia, Komal" sort="Zia, Komal" uniqKey="Zia K" first="Komal" last="Zia">Komal Zia</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000575 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000575 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32238094 |texte= Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32238094" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |